Docetaxel (DTX) plus cisplatin (CDDP) in locally advanced or metastatic head and neck cancer (HN). A phase II study.

被引：0
|
作者：
Caponigro, F
Avallone, A
Rivellini, F
Sguotti, C
Manzione, L
De Lucia, L
Biglietto, M
Massa, E
Comella, P
Mantovani, G
Comella, G
机构：
[1] Natl Tumor Inst Naples, So Italy Cooperat Oncol Grp, Naples, Italy
[2] Rhone Poulenc Rorer, Orrigio, Italy
来源：
CLINICAL CANCER RESEARCH | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
218
引用
收藏
页码：3773S / 3773S
页数：1
相关论文
共 50 条
  • [21] Phase I/II study of docetaxel plus FOLFOX in locally advanced or metastatic gastric cancer patients
    Filippelli, G.
    Lucia, M.
    La Gattuta, G.
    Caputo, A.
    Olivito, V
    Talarico, R.
    De Simone, R.
    Dima, G.
    ANNALS OF ONCOLOGY, 2006, 17 : 28 - 28
  • [22] A Phase II Study of Docetaxel, Cisplatin and 5-Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas
    Ansari, M.
    Omidvari, S.
    Mosalaei, A.
    Ahmadloo, N.
    Mosleh-Shirazi, M. A.
    Mohammadianpanah, M.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2011, 13 (03) : 187 - 191
  • [23] Docetaxel, cisplatin, fluorouracil, and leucovorin in locally advanced head and neck cancer -: In reply
    Colevas, AD
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1394 - 1395
  • [24] A phase II trial evaluating weekly docetaxel and capacitabine in patients with metastatic or advanced, locally, recurrent head and neck cancer
    Zhang, J.
    Lee, J. S.
    Urba, S.
    Worden, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Final results of a phase II study of erlotinib, docetaxel and cisplatin in patients with recurrent/metastatic head and neck cancer
    Kim, E. S.
    Kies, M. S.
    Glisson, B. S.
    Tsao, A.
    Ginsberg, L. E.
    Holsinger, F. C.
    Burke, B. J.
    Truong, M.
    Papadimitrakopoulou, A.
    Lippman, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer
    Allal, AS
    Zwahlen, D
    Becker, M
    Dulguerov, P
    Mach, N
    CANCER JOURNAL, 2006, 12 (01): : 63 - 68
  • [27] Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial
    Imamura, Yoshinori
    Tanaka, Kaoru
    Kiyota, Naomi
    Hayashi, Hidetoshi
    Ota, Ichiro
    Arai, Akihito
    Iwae, Shigemichi
    Minami, Shujiro
    Yane, Katsunari
    Yamazaki, Tomoko
    Nagatani, Yoshiaki
    Toyoda, Masanori
    Takahama, Takayuki
    Sakai, Kazuko
    Nishio, Kazuto
    Otsuki, Naoki
    Nibu, Ken-ichi
    Minami, Hironobu
    MEDICAL ONCOLOGY, 2021, 38 (11)
  • [28] Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial
    Yoshinori Imamura
    Kaoru Tanaka
    Naomi Kiyota
    Hidetoshi Hayashi
    Ichiro Ota
    Akihito Arai
    Shigemichi Iwae
    Shujiro Minami
    Katsunari Yane
    Tomoko Yamazaki
    Yoshiaki Nagatani
    Masanori Toyoda
    Takayuki Takahama
    Kazuko Sakai
    Kazuto Nishio
    Naoki Otsuki
    Ken-ichi Nibu
    Hironobu Minami
    Medical Oncology, 2021, 38
  • [29] Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study
    Schrijvers, D
    Van Herpen, C
    Kerger, J
    Joosens, E
    Van Laer, C
    Awada, A
    Van den Weyngaert, D
    Nguyen, H
    Le Bouder, C
    Castelijns, JA
    Kaanders, J
    De Mulder, P
    Vermorken, JB
    ANNALS OF ONCOLOGY, 2004, 15 (04) : 638 - 645
  • [30] HIGH-DOSE CISPLATIN FOR LOCALLY ADVANCED OR METASTATIC HEAD AND NECK-CANCER - A PHASE-II PILOT-STUDY
    HAVLIN, KA
    KUHN, JG
    MYERS, JW
    OZOLS, RF
    MATTOX, DE
    CLARK, GM
    VONHOFF, DD
    CANCER, 1989, 63 (03) : 423 - 427
12345